John Paolini - Net Worth and Insider Trading
John Paolini Net Worth
The estimated net worth of John Paolini is at least $1 Million dollars as of 2025-04-27. John Paolini is the CHIEF MEDICAL OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 52,038 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $1 Million. Details can be seen in John Paolini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Paolini has not made any transactions after 2024-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of John Paolini
John Paolini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Paolini owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .
Click here to see the complete history of John Paolini’s form 4 insider trades.
Insider Ownership Summary of John Paolini
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
KNSA | Kiniksa Pharmaceuticals International PLC | 2024-09-03 | Chief Medical Officer |
John Paolini Latest Holdings Summary
John Paolini currently owns a total of 1 stock. John Paolini owns 52,038 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of September 3, 2024, with a value of $1 Million.
Latest Holdings of John Paolini
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KNSA | Kiniksa Pharmaceuticals International PLC | 2024-09-03 | 52,038 | 21.37 | 1,111,792 |
Holding Weightings of John Paolini
John Paolini Form 4 Trading Tracker
According to the SEC Form 4 filings, John Paolini has made a total of 7 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 60,692 shares on September 3, 2024, which brought John Paolini around $2 Million.
Insider Trading History of John Paolini
- 1
John Paolini Trading Performance
John Paolini Ownership Network
Ownership Network List of John Paolini
Ownership Network Relation of John Paolini

John Paolini Owned Company Details
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
John Paolini is the Chief Medical Officer of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Group VP & Rilonacept GM Ross Moat , Chief Business Officer Eben Tessari , and Interim CFO Mark Ragosa .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, John Paolini made 4 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 121,448. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 144,426 shares made by Eben Tessari , a net sale of 139,852 shares made by Mark Ragosa , and a net sale of 309,021 shares made by Sanj K Patel .
In summary, during the past 3 months, insiders sold 138,378 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 138,378 shares. During the past 18 months, 843,310 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 843,310 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
John Paolini Mailing Address
Above is the net worth, insider trading, and ownership report for John Paolini. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John Paolini's mailing address is: Hamilton D0 Hm11.